Archive for 'Tag Archives: 'Diabetes''

Endo Tools Therapeutics raises €2.5 million in funding for clinical trials in obesity treatment

Endo Tools Therapeutics raises €2.5 million in funding for clinical trials in obesity treatment

Endo Tools Therapeutics, a spin-off from the ULB (Universite Libre of Brussels, Belgium) and developer of advanced endoscopic medical devices to treat obesity, digestive tract tumors and type II diabetes has announced the closure of a [...]

UCL makes new discovery with intestinal bacterium that may fight obesity and diabetes

UCL makes new discovery with intestinal bacterium that may fight obesity and diabetes

New research on obesity and diabetes led by Professor Patrice D. Cani, research associate of the FRS-FNRS at the Louvain Drug Research Institute (UCL) and investigator for WELBIO (UCL), has recently been published in the prestigious [...]

ZENTECH BIOTECHNOLOGY of Liège Science Park in Belgium is now incorporated in ASIA!

ZENTECH BIOTECHNOLOGY of Liège Science Park in Belgium is now incorporated in ASIA!

ZENTECH BIOTECHNOLOGY ASIA, based in Singapore, has recently been incorporated and has proudly announced that the implementation of its ASEAN strategy is well under way. Since 2006, ZenTech has targeted Asia and more specifically the ASEAN [...]

Prestigious European Albert Renold Award granted to Professor Decio L. Eizirik of the Universite Libre de Bruxelles (ULB).

Prestigious European Albert Renold Award granted to Professor Decio L. Eizirik of the Universite Libre de Bruxelles (ULB).

Dr. Decio L. Eizirik, Laboratory Director and Professor at the Medical Faculty, Université Libre de Bruxelles (ULB), since 2002, has been selected for the 2012 Albert Renold Prize by the European Association for the Study of [...]

Nanomedicine expert LDRI (UCL, Belgium) partners in European program to find oral alternative for Diabetics.

Nanomedicine expert LDRI (UCL, Belgium) partners in European program to find oral alternative for Diabetics.

The Louvain Drug Research Institute (LDRI) of the Catholic University of Louvain (UCL), expert in nanomedecine, is participating in a new European program in a fight against diabetes. The aim is to develop new methods of [...]